Cargando…
Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition
BACKGROUND: The treatment of microbial infections is becoming increasingly challenging because of limited therapeutic options and the growing number of pathogenic strains that are resistant to current antibiotics. There is an urgent need to identify molecules with novel modes of action to facilitate...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981992/ https://www.ncbi.nlm.nih.gov/pubmed/27514659 http://dx.doi.org/10.1186/s12864-016-2949-y |
_version_ | 1782447689871392768 |
---|---|
author | Li, Haoxin Cowie, Andrew Johnson, John A. Webster, Duncan Martyniuk, Christopher J. Gray, Christopher A. |
author_facet | Li, Haoxin Cowie, Andrew Johnson, John A. Webster, Duncan Martyniuk, Christopher J. Gray, Christopher A. |
author_sort | Li, Haoxin |
collection | PubMed |
description | BACKGROUND: The treatment of microbial infections is becoming increasingly challenging because of limited therapeutic options and the growing number of pathogenic strains that are resistant to current antibiotics. There is an urgent need to identify molecules with novel modes of action to facilitate the development of new and more effective therapeutic agents. The anti-mycobacterial activity of the C17 diyne natural products falcarinol and panaxydol has been described previously; however, their mode of action remains largely undetermined in microbes. Gene expression profiling was therefore used to determine the transcriptomic response of Mycobacterium smegmatis upon treatment with falcarinol and panaxydol to better characterize the mode of action of these C17 diynes. RESULTS: Our analyses identified 704 and 907 transcripts that were differentially expressed in M. smegmatis after treatment with falcarinol and panaxydol respectively. Principal component analysis suggested that the C17 diynes exhibit a mode of action that is distinct to commonly used antimycobacterial drugs. Functional enrichment analysis and pathway enrichment analysis revealed that cell processes such as ectoine biosynthesis and cyclopropane-fatty-acyl-phospholipid synthesis were responsive to falcarinol and panaxydol treatment at the transcriptome level in M. smegmatis. The modes of action of the two C17 diynes were also predicted through Prediction of Activity Spectra of Substances (PASS). Based upon convergence of these three independent analyses, we hypothesize that the C17 diynes inhibit fatty acid biosynthesis, specifically phospholipid synthesis, in mycobacteria. CONCLUSION: Based on transcriptomic responses, it is suggested that the C17 diynes act differently than other anti-mycobacterial compounds in M. smegmatis, and do so by inhibiting phospholipid biosynthesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12864-016-2949-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4981992 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49819922016-08-13 Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition Li, Haoxin Cowie, Andrew Johnson, John A. Webster, Duncan Martyniuk, Christopher J. Gray, Christopher A. BMC Genomics Research Article BACKGROUND: The treatment of microbial infections is becoming increasingly challenging because of limited therapeutic options and the growing number of pathogenic strains that are resistant to current antibiotics. There is an urgent need to identify molecules with novel modes of action to facilitate the development of new and more effective therapeutic agents. The anti-mycobacterial activity of the C17 diyne natural products falcarinol and panaxydol has been described previously; however, their mode of action remains largely undetermined in microbes. Gene expression profiling was therefore used to determine the transcriptomic response of Mycobacterium smegmatis upon treatment with falcarinol and panaxydol to better characterize the mode of action of these C17 diynes. RESULTS: Our analyses identified 704 and 907 transcripts that were differentially expressed in M. smegmatis after treatment with falcarinol and panaxydol respectively. Principal component analysis suggested that the C17 diynes exhibit a mode of action that is distinct to commonly used antimycobacterial drugs. Functional enrichment analysis and pathway enrichment analysis revealed that cell processes such as ectoine biosynthesis and cyclopropane-fatty-acyl-phospholipid synthesis were responsive to falcarinol and panaxydol treatment at the transcriptome level in M. smegmatis. The modes of action of the two C17 diynes were also predicted through Prediction of Activity Spectra of Substances (PASS). Based upon convergence of these three independent analyses, we hypothesize that the C17 diynes inhibit fatty acid biosynthesis, specifically phospholipid synthesis, in mycobacteria. CONCLUSION: Based on transcriptomic responses, it is suggested that the C17 diynes act differently than other anti-mycobacterial compounds in M. smegmatis, and do so by inhibiting phospholipid biosynthesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12864-016-2949-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-11 /pmc/articles/PMC4981992/ /pubmed/27514659 http://dx.doi.org/10.1186/s12864-016-2949-y Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Li, Haoxin Cowie, Andrew Johnson, John A. Webster, Duncan Martyniuk, Christopher J. Gray, Christopher A. Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition |
title | Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition |
title_full | Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition |
title_fullStr | Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition |
title_full_unstemmed | Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition |
title_short | Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition |
title_sort | determining the mode of action of anti-mycobacterial c17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981992/ https://www.ncbi.nlm.nih.gov/pubmed/27514659 http://dx.doi.org/10.1186/s12864-016-2949-y |
work_keys_str_mv | AT lihaoxin determiningthemodeofactionofantimycobacterialc17diynenaturalproductsusingexpressionprofilingevidenceforfattyacidbiosynthesisinhibition AT cowieandrew determiningthemodeofactionofantimycobacterialc17diynenaturalproductsusingexpressionprofilingevidenceforfattyacidbiosynthesisinhibition AT johnsonjohna determiningthemodeofactionofantimycobacterialc17diynenaturalproductsusingexpressionprofilingevidenceforfattyacidbiosynthesisinhibition AT websterduncan determiningthemodeofactionofantimycobacterialc17diynenaturalproductsusingexpressionprofilingevidenceforfattyacidbiosynthesisinhibition AT martyniukchristopherj determiningthemodeofactionofantimycobacterialc17diynenaturalproductsusingexpressionprofilingevidenceforfattyacidbiosynthesisinhibition AT graychristophera determiningthemodeofactionofantimycobacterialc17diynenaturalproductsusingexpressionprofilingevidenceforfattyacidbiosynthesisinhibition |